Michael Snyder answers Genome Biology's questionson the human and professional stories underlying hisSnyderome integrative omics project. Much excitement has surrounded the potential to applyhigh-throughput technologies to personalized medicine.The promise of omics in the clinic could mean not onlytailored treatments but early pinpointing of diseasestates. In the current issue of Cell, Michael Snyder(Box 1) and colleagues present what they term an 'iPOP'(integrative Personal Omics Profile), which includes thegenome, transcriptome, proteome, metabolome andauto-antibody profile of a single individual assayed over a14-month period [1].
展开▼
